C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 114 filers reported holding C4 THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $179,286 | -30.2% | 65,195 | -20.3% | 0.00% | – |
| Q1 2023 | $256,698 | -45.8% | 81,751 | 0.0% | 0.00% | – |
| Q4 2022 | $473,320 | -32.6% | 81,751 | -0.0% | 0.00% | – |
| Q3 2022 | $702,468 | +7.3% | 81,787 | -7.8% | 0.00% | – |
| Q2 2022 | $654,582 | -68.0% | 88,689 | +4.4% | 0.00% | -100.0% |
| Q1 2022 | $2,048,154 | +217.1% | 84,966 | +330.4% | 0.00% | – |
| Q4 2021 | $646,000 | -25.4% | 19,742 | +1.8% | 0.00% | -100.0% |
| Q3 2021 | $866,000 | +19.9% | 19,390 | +1.6% | 0.00% | 0.0% |
| Q2 2021 | $722,000 | +219.5% | 19,082 | +211.9% | 0.00% | – |
| Q1 2021 | $226,000 | +10.2% | 6,118 | -1.0% | 0.00% | – |
| Q4 2020 | $205,000 | – | 6,180 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 1,642,210 | $14,402,000 | 1.72% |
| Soleus Capital Management, L.P. | 1,441,513 | $12,642,000 | 1.72% |
| Nextech Invest Ltd. | 375,857 | $3,296,000 | 1.06% |
| RTW INVESTMENTS, LP | 2,819,472 | $24,727,000 | 0.57% |
| ArrowMark Colorado Holdings LLC | 5,091,975 | $44,657,000 | 0.55% |
| WASATCH ADVISORS LP | 5,934,476 | $52,045,000 | 0.36% |
| HARBOR CAPITAL ADVISORS, INC. | 25,470 | $223,000 | 0.20% |
| Perceptive Advisors | 766,231 | $6,720,000 | 0.20% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 606,721 | $5,321,000 | 0.08% |
| Virtus ETF Advisers LLC | 19,305 | $169,000 | 0.07% |